Medical experts kick as FDA panel recommends Moderna COVID vaccine for kids

FILE - In this Sunday, Aug. 15, 2021 file photo, vials of the Moderna COVID-19 vaccine are seen at the Assad Iben El Fourat school in Oued Ellil, outside Tunisa. The European Medicines Agency said a booster dose of Moderna’s coronavirus vaccine “can be considered” in people aged 18 and above. In a statement on Monday, Oct. 25, the EU drug regulator said its analysis had shown that a third dose given of Moderna’s vaccine - which is usually given in a two-dose schedule - at least six months after the second dose, led to an increase in antibody levels in adults whose levels were waning. (AP Photo/Hassene Dridi, file)
Spread the love

Experts have expressed their concerns over the U.S. Food and Drug Administration’s (FDA) vaccine advisory panel which voted unanimously to recommend Moderna’s COVID-19 vaccine for children ages 6 to 17.

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 22 to 0 to recommend Moderna’s two-dose vaccine for 6- to 11-year-olds at half the strength of the adult version, and 22 to 0 in favor of authorizing the shot for 12- to 17-year-olds at the same strength as adults.

During the public comment session of the meeting, individuals expressed concern over recommending a vaccine for an age group that has an almost zero risk of experiencing severe illness or death from COVID-19 and has already acquired a high level of natural immunity.

READ ALSODeaths, heart attack linked to COVID Vaccines on increase

Dr. Harvey Klein, orthopedic surgeon, mechanical engineer and rocket scientist said he is appalled at the FDA’s arrogance in even “thinking of vaccinating healthy children with outdated, highly toxic COVID vaccines.”

“Children have a “99.998% recovery rate with no sequelae if they get COVID. Vaccine Adverse Event Reporting System (VAERS) statistics show children ages birth to 18 who have been vaccinated with Pfizer-BioNTech and Moderna’s so-called vaccines have had severe life-threatening adverse reactions, such as myocarditis, Guillain-Barré Syndrome and many more severe adverse reactions including death.

“We know that VAERS is underreported by a factor of 100. The data cries out loudly to stop this insanity immediately before you kill or maim one more innocent child.”

Klein said the risks don’t outweigh the benefits as children from birth up to age 18 have a survival rate of 99.9% and virtually zero risk of death.

READ ALSOU.S drops COVID-19 test requirement for inbound air travellers

“Why in the world would you want to try to improve on perfection by exposing them to significant chances of being permanently severely injured or dead?” Klein asked. “The risk is infinite, the benefits are non-existent and the efficacy is extremely negative.”

Dr. David Gortler is a pharmacologist, pharmacist, FDA and healthcare policy oversight fellow and FDA reform advocate at the Ethics and Public Policy Center in Washington, D.C.

Gortler said the FDA has failed to address genotoxicity, teratogenicity, oncogenicity of COVID-19 vaccines and cardiovascular risk following vaccination, potential fertility issues and clinical effects of spike proteins in donated or transfused blood.

“Assuming two doses per child, that means two million children must risk potentially serious side effects to prevent a single child from requiring intensive care due to COVID-19.”

Another analysis, by Kathy Dopp and Stephanie Seneff, Ph.D., shows COVID-19 vaccination increases a child’s risk of dying from infection.

“Children under 18 are also 51 times more likely to die from the vaccine than they are to die from COVID infection if not vaccinated,” Gortler said, citing the analysis. “In other words, there is no clinical or epidemiological justification for vaccination in this particular group.”

The CDC confirmed 635 cases of myocarditis, or heart inflammation, in the 5 to 17 age group out of almost 55 million doses of the Pfizer-BioNTech vaccine administered. The agency said the condition occurred most often in adolescent boys after receiving their second dose.

NO COMMENTS

LEAVE A REPLY